LifeMD Inc (LFMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, LifeMD Inc (LFMD) has a cash flow conversion efficiency ratio of -0.142x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.28 Million) by net assets ($23.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LifeMD Inc (LFMD) market capitalisation for the company's overall valuation and market capitalisation.
LifeMD Inc - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how LifeMD Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
LifeMD Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LifeMD Inc ranked by their cash flow conversion efficiency. Explore cash flow quality index of LifeMD Inc to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
D O Green Technologies Bhd
KLSE:7204
|
0.022x |
|
IFGL Refractories Limited
NSE:IFGLEXPOR
|
0.007x |
|
Elanor Commercial Property Fund
AU:ECF
|
0.066x |
|
Doktas Dokumculuk Ticaret ve Sanayi AS
IS:DOKTA
|
0.066x |
|
Atomera Inc
NASDAQ:ATOM
|
-0.175x |
|
King Core Electronics Inc
TW:6155
|
0.045x |
|
ALM Equity AB Pfd.
ST:ALM-PREF
|
-0.015x |
|
Axactor SE
OL:ACR
|
-0.040x |
Annual Cash Flow Conversion Efficiency for LifeMD Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of LifeMD Inc from 2011 to 2025. View LifeMD Inc (LFMD) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $23.16 Million | $8.28 Million | 0.358x | +108.26% |
| 2024-12-31 | $-4.05 Million | $17.51 Million | -4.329x | -373.20% |
| 2023-12-31 | $5.57 Million | $8.82 Million | 1.585x | -49.53% |
| 2022-12-31 | $-7.31 Million | $-22.94 Million | 3.139x | +344.99% |
| 2021-12-31 | $25.82 Million | $-33.09 Million | -1.281x | -108.68% |
| 2020-12-31 | $-821.76K | $-12.13 Million | 14.763x | +6731.00% |
| 2019-12-31 | $-1.13 Million | $251.41K | -0.223x | +79.85% |
| 2018-12-31 | $819.74K | $-905.52K | -1.105x | +15.81% |
| 2017-12-31 | $622.84K | $-817.22K | -1.312x | -216.35% |
| 2016-12-31 | $-361.73K | $-407.91K | 1.128x | +169.16% |
| 2015-12-31 | $180.99K | $-295.12K | -1.631x | -580.24% |
| 2014-12-31 | $-139.50K | $33.44K | -0.240x | +81.91% |
| 2013-12-31 | $195.49K | $-259.07K | -1.325x | +22.12% |
| 2012-12-31 | $135.00K | $-229.73K | -1.702x | -2822.77% |
| 2011-12-31 | $-282.98K | $-17.69K | 0.062x | -- |
About LifeMD Inc
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature e… Read more